Tetra Discovery Partners Initiates Phase 2 Trial in Fragile X Syndrome
July 11, 2018
Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome – Business Wire, July 10, 2018
Vestaron Raising $12M to Commercialize Biopesticide
July 9, 2018
Agtech startup raising $12M to commercialize biopesticide – MiBiz, July 7, 2018
Gemphire Therapeutics Achieves Primary Endpoint in its Phase 2b INDIGO-1 Trial
June 29, 2018
Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients – Gemphire Therapeutics Press Release, June 29, 2018
Vestaron Appoints Anna Rath as Chief Executive Officer
Vestaron Appoints Anna Rath as Chief Executive Officer – Vestaron Press Release, June 20, 2018
First Look: Reconstruct
June 7, 2018
First Look: Reconstruct – engineering.com, May 29, 2018
BlueWillow Biologics Announces Issuance of Therapeutic Cancer Vaccine Patent
June 6, 2018
BlueWillow Biologics Announces Issuance of Therapeutic Cancer Vaccine Patent – Press Release, May 30, 2018
Blue Medora Announces BindPlane for Microsoft Azure Log Analytics
May 21, 2018
Blue Medora Announces Multi-Cloud Monitoring for Microsoft Azure Log Analytics – Globe Newswire, 5/21/18
Despite growth, more angel investors needed in state
May 1, 2018
Despite growth, more angel investors needed in state – MiBiz 4/29/18
Blue Medora Launches BindPlane
Blue Medora Launches Industry’s First IT Monitoring Integration as-a-Service, BindPlane – Globe Newswire 2/20/18
Tetra Discovery Partners Inc. to Launch Clinical Trial
April 2, 2018
GR drug developer to test compound as treatment for genetic form of autism – MiBiz 4/1/18